Mcl‐1 targeting could be an intriguing perspective to cure cancer-Reference-Cited by-同舟云学术

Mcl‐1 targeting could be an intriguing perspective to cure cancer

Published:2018-05-24 Issue:11 Volume:233 Page:8482-8498
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

De Blasio Anna¹²^ORCID,Vento Renza¹²³^ORCID,Di Fiore Riccardo¹²³^ORCID

Affiliation:

1. Laboratory of Biochemistry, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies University of Palermo, Polyclinic Palermo Italy

2. Associazione Siciliana per la Lotta contro i Tumori (ASLOT) Palermo Italy

3. Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology Temple University Philadelphia Pennsylvania

Funder

European Regional Development Fund

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26786

Reference164 articles.

1. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

2. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells

3. Validation of the Antiproliferative Effects of Organic Extracts from the Green Husk ofJuglans regiaL. on PC-3 Human Prostate Cancer Cells by Assessment of Apoptosis-Related Genes